Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

BioImagene Announces US Labs as Its First Strategic Customer to Launch an Innovative Digital Pathology Solution.


SAN JOSE San Jose, city, United States
San Jose (sănəzā`, săn hōzā`), city (1990 pop. 782,248), seat of Santa Clara co., W central Calif.; founded 1777, inc. 1850.
, Calif. -- US LABS offers its Virtual Image(TM) digital pathology pathology, study of the cause of disease and the modifications in cellular function and changes in cellular structure produced in any cell, organ, or part of the body by disease.  solution, built on iHarness, to all customers within its network

BioImagene, the innovative provider of digital pathology solutions, announced that US LABS, a national, anatomic anatomic /ana·tom·ic/ (an?ah-tom´ik) anatomical.
Anatomic
Related to the physical structure of an organ or organism.
 pathology reference laboratory devoted to comprehensive, high quality, rapid response cancer testing, has selected its iHarness-powered image analysis solution to offer Virtual Image, a unique service, to its network of pathologists
  • Max Bielschowsky
  • Paul Ehrlich - (1854 - 1915)
  • Gustav Giemsa - (1867 - 1948) (see Giemsa stain)
  • Ludwig Grünwald
  • William Boog Leishman - (1865 - 1926) (see leishmaniasis)
  • Richard May
  • Frank Burr Mallory (1862 - 1941) (see Mallory bodies)
 and pathology centers.

US LABS' Virtual Image is launched as an innovative addition to the suite of services it already offers to its network of pathologists and pathology centers. Virtual Image(TM) is a revolutionary new system that works in concert with the pathologist pa·thol·o·gist
n.
A specialist in pathology who practices chiefly in the laboratory as a consultant to clinical colleagues.


Pathologist 
, emulates a 20X microscope, and shortens the turnaround time (1) In batch processing, the time it takes to receive finished reports after submission of documents or files for processing. In an online environment, turnaround time is the same as response time.  for accurate image analysis. US Labs has launched this service, built on BioImagene's digital pathology platform, iHarness. With an Internet-based solution, US LABS' customers will be able to analyze images anytime, anywhere and will be able to share them with their colleagues for immediate second opinions, resulting in the tremendous benefits of quicker analysis and reduced costs.

"iHarness reduced the average analysis time from 20 minutes per case to around 2 minutes per case -- a 90% time savings. The implementation was very efficient and the transition to the new system was extremely smooth," said Matt Watson, Vice President of Operations at US LABS.

"Together, US LABS and BioImagene are making tremendous progress toward achieving our objective of enabling and advancing digital pathology. BioImagene was very supportive during the implementation of our Virtual Image product. Their team was highly responsive and we were delighted with their commitment and dedication to delivering this product on time," said R. Judd Jessup, Chief Executive Officer of US LABS.

"We are very happy to announce the live deployment of iHarness at US LABS. We have been working with US Labs very closely to enable their Virtual Image service and this is a great example of our ultimate vision of enabling truly digital pathology," said BioImagene Chief Executive Officer, Mohan Uttarwar.

About US LABS

Irvine-based US LABS is a national, anatomic pathology reference laboratory devoted to comprehensive, high quality, rapid response cancer testing. The company provides diagnostic, prognostic prog·nos·tic
adj.
1. Of, relating to, or useful in prognosis.

2. Of or relating to prediction; predictive.

n.
1. A sign or symptom indicating the future course of a disease.

2.
, and predictive cancer testing services to hospitals, physician offices, surgery centers, and research institutions.

About BioImagene

BioImagene provides sophisticated bio-image analysis products built on iHarness, its patent-pending technology platform. BioImagene's products allow pathologists and researchers to analyze and interpret images with far greater speed and consistency. The data management systems of BioImagene's technology facilitate communication and collaboration Working together on a project. See collaborative software. , improving the standard of patient care and increasing the speed of drug discovery. Its scalable digital pathology solutions have been embraced by clinicians, industry and researchers alike.

BioImagene is headquartered in San Jose, California San Jose (IPA: /ˌsænhoʊˈzeɪ/) is the third-largest city in California, and the tenth-largest in the United States. It is the county seat of Santa Clara County. . For more information on BioImagene, visit the company's web site at www.bioimagene.com.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Sep 27, 2004
Words:468
Previous Article:Utility Trailer Marks 90th Anniversary With New Milestones.
Next Article:Polar Air Cargo Launches Web-Based Quality Management Tool; Global Implementation Improves Customer Service, Safety and Communication.



Related Articles
Bioimagene Launches; Introduces an Innovative Solution to Enable Digital Pathology.
BioImagene Secured $4.2 Million in Series B Financing Led by Tuputele Ventures and Authosis Ventures.
Ohio State University College of Medicine Signs a Collaboration Agreement on Digital Pathology with BioImagene.
BioImagene Meets with FDA Officials to Discuss Pre-IDE Submission of the Diagnostic Product Version of Its PATHIAM(TM) Software.
BioImagene to Present at Medtech Insight and Windhover Information's ''In3 Medical Device Summit'' Conference, June 21-23, 2006 in San Francisco, CA.
DMetrix and BioImagene Partner to Create a Complete Digital Pathology Solution.
BioImagene Provides Global Digital Solutions in Indian Pathology Market.
BioImagene Announces a Collaboration with HP on High Content Analysis and Digital Pathology Solutions.
BioImagene Introduces Pathiam(TM) 3.0 (RUO)(1) - A Comprehensive and Affordable Digital Pathology Solution.
BioImagene Receives FDA Clearance for HER2/neu Application on Pathiam(TM) Imaging Software.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles